OPRM1, opioid receptor mu 1, 4988

N. diseases: 370; N. variants: 42
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1799971
rs1799971
Entrez Id: 4988
Gene Symbol: OPRM1
OPRM1
CUI: C0003467
Disease:
Anxiety
0.030 GeneticVariation BEFREE In the current study (N = 44), we expand upon what is known about children's genetic and environmental risk for anxiety by examining the unique and interactive effects of mother-child LSM and the OPRM1 polymorphism A118G on school-aged children's separation anxiety disorder (SAD) symptoms. 29576267 2018
dbSNP: rs1799971
rs1799971
Entrez Id: 4988
Gene Symbol: OPRM1
OPRM1
CUI: C0003467
Disease:
Anxiety
0.030 GeneticVariation BEFREE Functional alleles that alter alcoholism-related intermediate phenotypes include common alcohol dehydrogenase 1B and aldehyde dehydrogenase 2 variants that cause the aversive flushing reaction; catechol-O-methyltransferase (COMT) Val158Met leading to differences in three aspects of neurobiology: executive cognitive function, stress/anxiety response, and opioid function; opioid receptor micro1 (OPRM1) Asn40Asp, which may serve as a gatekeeper molecule in the action of naltrexone, a drug used in alcoholism treatment; and HTTLPR, which alters serotonin transporter function and appears to affect stress response and anxiety/dysphoria, which are factors relevant to initial vulnerability, the process of addiction, and relapse. 15584875 2004
dbSNP: rs1799971
rs1799971
Entrez Id: 4988
Gene Symbol: OPRM1
OPRM1
CUI: C0003467
Disease:
Anxiety
0.030 GeneticVariation BEFREE The data did not support a role for the Asn40Asp polymorphism in anxiety and depression, despite adequate statistical power to detect small effects. 12210283 2002
dbSNP: rs769540300
rs769540300
Entrez Id: 4988
Gene Symbol: OPRM1
OPRM1
CUI: C0003467
Disease:
Anxiety
0.010 GeneticVariation BEFREE Functional alleles that alter alcoholism-related intermediate phenotypes include common alcohol dehydrogenase 1B and aldehyde dehydrogenase 2 variants that cause the aversive flushing reaction; catechol-O-methyltransferase (COMT) Val158Met leading to differences in three aspects of neurobiology: executive cognitive function, stress/anxiety response, and opioid function; opioid receptor micro1 (OPRM1) Asn40Asp, which may serve as a gatekeeper molecule in the action of naltrexone, a drug used in alcoholism treatment; and HTTLPR, which alters serotonin transporter function and appears to affect stress response and anxiety/dysphoria, which are factors relevant to initial vulnerability, the process of addiction, and relapse. 15584875 2004